NCT05111717

Brief Summary

The purpose of this study is to demonstrate the molecular effect of desflurane on DNA by measuring the global DNA methylation level in patients under going lumbar spinal stenosis surgery under general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

November 8, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

November 17, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2021

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

March 15, 2023

Status Verified

March 1, 2023

Enrollment Period

1 month

First QC Date

October 17, 2021

Last Update Submit

March 14, 2023

Conditions

Keywords

Desflurane,DNA methylationepigeneticsinhalation anesthetics

Outcome Measures

Primary Outcomes (1)

  • Global DNA methylation change 5 minutes before and 120 minutes after anesthesia induction in peripheral blood mononuclear cells

    The global DNA methylation level will be measured 5 minutes before and 120 minutes after anesthesia induction.

    5 minutes before induction of anesthesia ,120 minutes after the beginning of anesthesia

Study Arms (1)

group 1

Peripheral venous blood samples will collected at two time points as follows: before the premedication and the induction of anesthesia (T₁): 120 minutes after the beginning of anesthesia (T₂). DNA will be obtained from blood samples , and global DNA methylation analysis will be done.

Drug: Desflurane

Interventions

Peripheral venous blood samplesof patients will collected at two time points as follows: before the premedication and the induction of anesthesia (T₁): 120 minutes after the beginning of anesthesia (T₂). Anesthesia maintenance will be provided with 40% O₂ and minimum alveolar concentration (MAC) in 60% air with 6% desflurane. DNA will be obtained from blood samples with the help of DNA isolation kit, and global DNA methylation analysis will performed by ELISA method.

group 1

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with physical status I and II of the American Society of Anesthesiologists (ASA), aged between 18-65 and scheduled for lumbar spinal surgery, which will take at least 120 minutes, will be included in the study

You may qualify if:

  • Ability to understand and willingness to sign an informed consent form
  • Elective lumbar spinal surgery that will take at least 120 minutes,
  • American Society of Anesthesiologists (ASA) physical status I and II
  • Be between the ages of 18 and 65

You may not qualify if:

  • Patients with ASA physical status III or IV disease
  • Smoking or alcohol consumption
  • Chronic systemic disease (diabetes mellitus,chronic pulmonary disorders, chronic kidney and liver disorders
  • recently received radiation, chemotherapy
  • malignancy
  • blood transfusion in operation
  • use of antioxidant supplements
  • have received general anesthesia in the last three months
  • Patients with known occupational exposures (operating room personnel, chemical plant workers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mugla Sıtkı Kocman University Training and research Hospital

Muğla, Turkey (Türkiye)

Location

Related Publications (3)

  • Chowdhury B, Cho IH, Irudayaraj J. Technical advances in global DNA methylation analysis in human cancers. J Biol Eng. 2017 Mar 1;11:10. doi: 10.1186/s13036-017-0052-9. eCollection 2017.

    PMID: 28261325BACKGROUND
  • Jaloszynski P, Kujawski M, Wasowicz M, Szulc R, Szyfter K. Genotoxicity of inhalation anesthetics halothane and isoflurane in human lymphocytes studied in vitro using the comet assay. Mutat Res. 1999 Feb 19;439(2):199-206. doi: 10.1016/s1383-5718(98)00195-8.

    PMID: 10023059BACKGROUND
  • Bilban M, Jakopin CB, Ogrinc D. Cytogenetic tests performed on operating room personnel (the use of anaesthetic gases). Int Arch Occup Environ Health. 2005 Feb;78(1):60-4. doi: 10.1007/s00420-004-0579-1. Epub 2005 Feb 10.

    PMID: 15703947BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

peripheral venous blood sample

MeSH Terms

Interventions

Desflurane

Intervention Hierarchy (Ancestors)

Ethyl EthersEthersOrganic ChemicalsMethyl EthersHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbons

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

October 17, 2021

First Posted

November 8, 2021

Study Start

November 17, 2021

Primary Completion

December 25, 2021

Study Completion

December 30, 2021

Last Updated

March 15, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

via mail

Locations